Wu, Shun
Guo, Fang
Li, Manxiu
Chen, Wei
Jin, Liting
Funding for this research was provided by:
Hubei Provincial Natural Science Foundation (2019CFC927)
Article History
Received: 27 March 2024
Accepted: 9 October 2024
First Online: 29 October 2024
Declarations
:
: This study was approved by the Ethics Committee of Wuhan Myhalic Biotechnology Co., Ltd. All methods were performed in accordance with the relevant guidelines and regulations.
: The authors declare no competing interests.
: The study is reported in accordance with ARRIVE guidelines.